Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil

<p>Abstract</p> <p>Background</p> <p>Lamivudine is an oral nucleoside analogue widely used for the treatment of chronic hepatitis B. The main limitation of lamivudine use is the selection of resistant mutations that increases with time of utilization. Hepatitis B virus...

Full description

Bibliographic Details
Main Authors:	Brandão Carlos E, Amendola Marcia, Ó Kycia MR, Souto Francisco JD, Bottecchia Marcelle, Niel Christian, Gomes Selma A
Format:	Article
Language:	English
Published:	BMC 2008-01-01
Series:	BMC Microbiology
Online Access:	http://www.biomedcentral.com/1471-2180/8/11

Similar Items

Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes
by: Damerow, Hans
Published: (2012)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiencyvirus/hepatitis B virus co-infected patients in Brazil
by: Adriana Cristina da Silva, et al.
Published: (2010-09-01)

Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates
by: Virgolino Helaine A, et al.
Published: (2007-11-01)

Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction
by: Yong-Zhong Wang, et al.
Published: (2011-11-01)

Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction
by: Yong-Zhong Wang, et al.

Genotypes and resistance loci in patients with chronic hepatitis B achieving virologic breakthrough in treatment with lamivudine combined with adefovir after developing drug resistance in treatment with lamivudine alone
by: YANG Dongqiang, et al.
Published: (2016-03-01)

Lamivudina por tempo prolongado no tratamento da hepatite B crônica no estado de Mato Grosso Long-term use of lamivudine for treating chronic hepatitis B in the State of Mato Grosso
by: Francisco José Dutra Souto, et al.
Published: (2007-02-01)

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?
by: Andrea Giacomelli, et al.
Published: (2020-06-01)

HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review
by: Xiu-Li Chen, et al.
Published: (2013-01-01)

Screening for hepatitis B virus in Maracanã workers
by: Marcelle Bottecchia
Published: (2015-01-01)

Nonresponse to 18-month Lamivudine Monotherapy in Chronic Hepatitis B Patients with Dual Genotype B and C Infection and Acute Exacerbation
by: Ming-Jen Sheu, et al.
Published: (2006-01-01)

Hepatitis B Virus Genotype D Isolates Circulating in Chapecó, Southern Brazil, Originate from Italy.
by: Carolina Souza Gusatti, et al.
Published: (2015-01-01)

Geographic distribution of hepatitis C virus genotypes in Brazil
by: Campiotto S., et al.
Published: (2005-01-01)

Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations
by: Michel VF Sucupira, et al.
Published: (2006-09-01)

Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy
by: Huang M, et al.
Published: (2019-10-01)

Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine
by: Soudbakhsh A, et al.
Published: (2011-06-01)

Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients.
by: Marianoel Pereira-Gómez, et al.
Published: (2016-01-01)

Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine
by: R Ehsani
Published: (2012-05-01)

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
by: Hongcan Liu, et al.
Published: (2021-04-01)

Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine
by: R Rafiei Tabatabaei, et al.
Published: (2011-06-01)

Hepatitis G virus infection and genotypes in Iraqi thalassemia patients
by: Maryam S Ibrahim, et al.
Published: (2015-01-01)

Prevalence and genotypes of GB Virus C/Hepatitis G virus among blood donors in Central Brazil
by: Luciana A Oliveira, et al.
Published: (2002-10-01)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
by: Wang Li-Chun, et al.
Published: (2009-10-01)

Hepatitis B virus genotypes in Southeast Brazil and its relationship with histological features
by: Leticia Cancella Nabuco, et al.
Published: (2012-09-01)

YMDD motif mutation after lamivudine therapy
by: Jazayeri Seyed, et al.
Published: (2011-01-01)

Hepatitis C: genotyping
by: Norma de Paula Cavalheiro

Prevalence of hepatitis C virus genotypes in the State of Pará, Brazil
by: Vanessa de Souza Guimarães, et al.

Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions
by: Alba Maria Xavier Eloy, et al.

Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions
by: Alba Maria Xavier Eloy, et al.
Published: (2013-11-01)

Lamivudine treatment for severe acute HBV hepatitis
by: Andrea Lisotti, Francesco Azzaroli, Federica Buonfiglioli, Marco Montagnani, Flavio Alessandrelli, Giuseppe Mazzella
Published: (2008-01-01)

Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01)

Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers
by: Flávia Miryan Martins Almeida de Mello, et al.
Published: (2014-12-01)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
by: Jeong Han Kim, et al.
Published: (2013-09-01)

Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil
by: Aldemir B Oliveira-Filho, et al.
Published: (2010-02-01)

Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes
by: Renata C Ferreira, et al.
Published: (2006-09-01)

IDENTIFICATION OF X GENE MUTATIONS, GENOTYPE AND SUBGENOTYPE OF HEPATITIS B VIRUS (HBV)
by: Fatimawali, et al.
Published: (2014-10-01)

Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus
by: Aqsa Ikram, et al.
Published: (2018-12-01)

Prevalence and Characteristics of Precore Mutation in Iran and Its Correlation with Genotypes of Hepatitis B
by: Ali Kargar Kheirabad, et al.
Published: (2017-04-01)